Methamphetamine use: can you reduce without quitting?
Part of Mental health clinical trials.
This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have used methamphetamine in the past week and have a positive urine test.
- You meet criteria for moderate to severe methamphetamine use disorder.
- You want treatment for your meth use and can stay in the study for 12 weeks plus a 12-week follow-up.
- If you take buprenorphine or methadone for opioid use disorder, you can still join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called troriluzole can help people who use methamphetamine. If you have methamphetamine use disorder and are not seeking treatment right now, this study may be an option for you.
This study provides extra support to help people with heart failure who use methamphetamine to quit. The goal is to see if this support helps improve their heart health and overall well-being.
This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.
This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.
This study tests whether tirzepatide, a medication that may help reduce cravings and weight, can help people who use methamphetamine cut down or stop. It aims to find a new treatment option for methamphetamine use disorder.
This study tests whether a high dose of a stimulant medication (lisdexamfetamine, an ADHD medicine) taken over many weeks can help people who have already completed a methamphetamine treatment program to stay off meth, reduce use, or avoid relapse.
Hear when a new Methamphetamine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.